Carcinoma: all 6,719 studies
Page 3 of 68. Open to participants first (1,142), then studies with results posted, then the rest; newest registration first within each.
- Single-Center Eval of Clinical & Radiological Benefit AHCC in Combo W/ SOC Tx for HPV+ Pts W/ HNSCCRecruitingNCT06693323Phase 2
- Combination of Toripalimab and JS004 Therapy for ccRCCRecruitingNCT06690697Phase 2
- Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of IPM514 in Patients with Esophageal Squamous Cell CarcinomaRecruitingNCT06690476Early Phase 1
- Mts105 for Advanced Hepatocellular CarcinomaRecruitingNCT06689540Phase 1
- Surgery Alone Verus Sugery Combined with Dose-reduced Radiotherapy for Newly Diagnosed Stage I Nasopharyngeal CarcinomaRecruitingNCT06688760Not applicable
- HPV Vaccine, Imiquimod, and Metformin Combination TrialRecruitingNCT06686043Phase 2
- Study of Dalpiciclib Isethionate Plus Pyrotinib Maleate in the Treatment of Advanced Esophageal Squamous Cell CarcinomaRecruitingNCT06684600Phase 2
- Ivonescimab in the Treatment of Multiple Advanced TumorsRecruitingNCT06683846Phase 2
- Cadonilimab Combined With Anlotinib Followed by Radiotherapy in Recurrent or Metastatic Esophageal Squamous Cell Carcinoma (CAR-RMEC)Not yet recruitingNCT06681285Phase 2
- Neoadjuvant and Adjuvant Sintilimab Combined with Chemoradiotherapy Versus Chemoradiotherapy Alone in Stage TanyN3M0 Nasopharyngeal CarcinomaNot yet recruitingNCT06680115Phase 2
- Serous Endometrial Intraepithelial Carcinoma (SEIC): Prospective Registration StudyNot yet recruitingNCT06677242
- Vorolanib in the Second-line Treatment of Patients With Unresectable or Metastatic Renal Cell CarcinomaRecruitingNCT06676527
- Under Whole-course of Immunotherapy, Gradient Fractionated RT with CCT Versus CFRT with CCT for LANPC Who Achieved PR Post Induction Chemotherapy.RecruitingNCT06675214Phase 3
- Neoantigen Vaccines in Esophageal Squamous Cell CarcinomaRecruitingNCT06675201Phase 2
- Sintilimab Combined SBRT As Neoadjuvant Therapy for Resectable HCC with PVTTRecruitingNCT06664996Phase 2
- Current Status of Diagnosis and Treatment of Uroepithelial CarcinomaNot yet recruitingNCT06663735
- Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or RadiationRecruitingNCT06662058Not applicable
- An Observational Study Using The LumAssure Device In Participants Undergoing Assessment Of Skin Conditions.Not yet recruitingNCT06661577
- Irinotecan Liposome Combined with S-1 in PD-1/L1 Inhibitor Refractory Recurrent or Metastatic NPCRecruitingNCT06657690Phase 2
- Endoscopic Retrograde Cholangiopancreatography With Radiofrequency Ablation (ERCP-RFA) Combined With Envafolimab and Surufatinib Sequential Therapy for Unresectable Biliary Tract CarcinomaNot yet recruitingNCT06656559Phase 2
- A Study of Simmitinib Versus Chemotherapy for Participants With Advanced Oesophageal Squamous Cell CarcinomaNot yet recruitingNCT06656091Phase 3
- Circulating Tumor Mitochondrial DNA (ct-mtDNA) As a Biomarker for Hepatocellular Carcinoma Recurrence SurveillanceRecruitingNCT06653062
- Clinical Study of SN301A Injection in the Treatment of Hepatocellular CarcinomaRecruitingNCT06652243Early Phase 1
- Radiotherapy Combined with Systemic Therapy Versus Systemic Therapy for Oligometastatic UTUCsRecruitingNCT06652022Not applicable
- Neoadjuvant Toripalimab + Chemotherapy ± Cetuximab in Locally Advanced Head and Neck Squamous Cell Carcinoma (Neo-ICT)Not yet recruitingNCT06647563Phase 3
- Institution of an Italian Multicenter Database of Patients with Parathyroid Carcinoma or Atypical Parathyroid AdenomaRecruitingNCT06645951
- Study on the Safety and Efficacy of BST06 Injection in the Treatment of Advanced Hepatocellular CarcinomaNot yet recruitingNCT06645314Early Phase 1
- [18F]F-FAPI PET-CT to Identify Carcinoma of Unknown Primary OriginRecruitingNCT06644716Not applicable
- Fecal Microbiota Transplantation in Reversing Drug Resistance in Unresectable HCC (TALENP004)Not yet recruitingNCT06643533
- HAIC Compared With TACE in Huge Hepatocellular CarcinomaRecruitingNCT06641713
- Study of TPEx Followed by a Maintenance With Avelumab and Cetuximab in First Line Recurrent or Metastatic Squamous Cell Carcinoma of the H&NRecruitingNCT06640725Phase 2
- Encorafenib + Cetuximab Beyond Progression in Combination With FOLFIRI in Patients With BRAF V600E Mutated Metastatic Colorectal Cancer Progressing on Encorafenib + Cetuximab.RecruitingNCT06640166Phase 2
- Therapeutic Effects of Immuno-targeted Therapy Combined With or Without RT for HCCNot yet recruitingNCT06639971
- A Trial of SHR-A2102 With Antitumor Therapy in Advanced Urothelial CarcinomaRecruitingNCT06639347Phase 1/2
- Benmelstobart Combined With Radiochemotherapy as Neoadjuvant Treatment Iin ESCCRecruitingNCT06637163Phase 2
- Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP TrialRecruitingNCT06636734Phase 2
- Clinicopathological Analysis of Endometrial Carcinoma in the View of Old and New International Federation of Gynecology and Obestetrics (FIGO)RecruitingNCT06632431
- HAIC in Combination with PD-1 Inhibitors and Lenvatinib for Intermediate and Advanced HCC After the Failure of Systemic Therapy Recommended by BCLCRecruitingNCT06632093
- Canadian Initiative to Measure, Predict and Assess Cancer Treatment Outcomes in Patients Treated With Immuno-OncotherapeuticsNot yet recruitingNCT06630273
- Ten-Year Outcomes of Operable Solitary Hepatocellular Carcinoma Patients: Impact of Tumor Size Over 6.5 Cm and Microvascular InvasionRecruitingNCT06628661
- Early Transjugular Intrahepatic Portosystemic Shunt for Advanced Hepatocellular CarcinomaRecruitingNCT06624098Not applicable
- Correlation Study of Lipid Metabolites as Markers of Hepatocellular CarcinomaRecruitingNCT06623474
- TIPS Combined With Lenvatinib and PD-1 Inhibitor for Advanced HCC With Main Trunk PVTTRecruitingNCT06622031Not applicable
- A Study of SCG101 TCR-T Cell Therpay in the Treatment of Subjects With Hepatitis B Virus-RelatedRecruitingNCT06617000Phase 1
- Patient-led Follow-up from Home After Surgery for Colorectal CarcinomaRecruitingNCT06613581Not applicable
- 68Ga-NY104 PET/CT Guided Radiation Therapy in CcRCC.RecruitingNCT06613269Phase 2
- Development of Tumor Organoids From Undifferentiated Primary Carcinomas to Guide Therapeutic DecisionsRecruitingNCT06612827
- Concurrent Nab-paclitaxel with Intensity-modulated Radiation Therapy in Patients with Stage III-IVa Nasopharyngeal CarcinomaRecruitingNCT06611150Phase 1
- Donafenib as Adjuvant Therapy Following Ablation for Recurrent HCCRecruitingNCT06609876Not applicable
- dTACE-HAIC Combined With Bevacizumab and Atezolizumab for Huge Hepatocellular CarcinomaRecruitingNCT06609863Not applicable
- The Comparison of TACE-Lenvatinib With TACE-Lenvatinib-ablation for Intermediate Recurrent Hepatocellular CarcinomaRecruitingNCT06609850Not applicable
- CHG0521 Oral Coating in Patients with Solid Tissue Tumor/Recurrent/Metastatic TSCCNot yet recruitingNCT06609070Not applicable
- mFOLFOX7 Plus Camrelizumab and Apatinib in BCLC Stage A/B Hepatocellular Carcinoma Patients Beyond Milan CriteriaRecruitingNCT06607107Phase 2
- GP Combined with Toripalimab Versus GP Induction Chemotherapy for Advanced Childhood Nasopharyngeal CarcinomaNot yet recruitingNCT06605131Phase 2
- Low-Dose Involved-Field Radiotherapy Plus Immunochemotherapy for ESCCRecruitingNCT06603402Phase 2
- Measuring the Density of Iodine in Lipiodol Depositions: Detecting an Invisible Residual Tumor After Conventional Transarterial Chemoembolization for Hepatocellular CarcinomaNot yet recruitingNCT06602986Not applicable
- Neoadjuvant Chemoimmunotherapy Followed by Surgery and Postoperative RadioimmunotherapyRecruitingNCT06602843Not applicable
- Reinforced and Non-Reinforced Staple Lines in Fissureless LobectomyNot yet recruitingNCT06602661Phase 1
- Triple Therapy for Intermediate-advanced HCC With BDTT (TALENP002)RecruitingNCT06602011
- A Phase 3 Study of AK112 Plus AK117 Versus Pembrolizumab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)RecruitingNCT06601335Phase 3
- Study of Adebrelimab With Chemotherapy, Endoscopy and Sequential Chemoradiotherapy In Inoperable Esophageal CancerNot yet recruitingNCT06599775Phase 2
- Postoperative Adjuvant Immunotherapy Combined with Radiotherapy Versus Surgery Alone in Locally Advanced UTUCRecruitingNCT06598761
- Atezolizumab and BEvacizumab With STereotactic Body Radiotherapy for Advanced Hepatocellular CarcinomaRecruitingNCT06595108Not applicable
- Endoscopic Variceal Ligation vs Carvedilol for the Prevention of First Esophageal Variceal Bleeding in Patients With HCCRecruitingNCT06594744Phase 4
- TACE With Thermosensitive Nanogel Versus Embosphere for HCCRecruitingNCT06593964Not applicable
- Single-Incision Gasless Endoscopic Total Thyroidectomy Via Subclavian Approach Versus Open Surgery for PTCRecruitingNCT06592755
- Second-line Systemic Therapy Combined with SBRT for HCC with Oligoprogression After Standard First-line Systemic TreatmentNot yet recruitingNCT06592612Phase 2
- Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous TreatmentRecruitingNCT06589804Phase 3
- Phase 1 Clinical Trial of FluBHPVE6E7 Immunotherapy for HPV16-Associated Oropharyngeal CancerRecruitingNCT06589609Phase 1
- BTLA Inhibitor (JS004) Combined with Toripalimab and Chemotherapy in the Perioperative Treatment of Resectable Locally Advanced Thoracic Esophageal Squamous Cell CarcinomaNot yet recruitingNCT06588335Phase 2
- Phase II Study of PD-1 Antibody Combined With Radiotherapy in Recurrent or Metastatic Adrenal Cortical CarcinomaRecruitingNCT06587802Phase 2
- Postoperative Adjuvant Therapy of Donafenib for Hepatocellular CarcinomaRecruitingNCT06581315Not applicable
- Surgery and Reducing Ionizing Radiation of the Unknown PrimaryNot yet recruitingNCT06578871Phase 2
- Evaluating the Use of Photodynamic Therapy to Treat Facial Cutaneous Squamous Cell Carcinoma in Situ (SCCis)RecruitingNCT06577311Phase 2
- Effects of Neoadjuvant Therapy With Carboplatin, Paclitaxel Combined With Anti-PD-1 Drugs on Cognitive Function in Patients With Resectable Head and Neck Squamous Cell CarcinomaRecruitingNCT06576180
- Effects of Neoadjuvant Therapy With Carboplatin, Paclitaxel Combined With Anti-PD-1 Drugs on Pain, Anxiety and Depression in Patients With Resectable Head and Neck Squamous Cell CarcinomaRecruitingNCT06575322
- Cardenilimab Combined With Lenvatinib in Patients With Perioperative Resectable Clear Cell Renal Cell Carcinoma.Not yet recruitingNCT06574412Phase 2
- Effect of Nurse-Led Individualized Follow-Up Intervention on Patients With Nasopharyngeal CarcinomaNot yet recruitingNCT06572293Not applicable
- Perioperative Risk of Immunotherapy Based Neoadjuvant and Conversion Therapy for Hepatocellular CarcinomaRecruitingNCT06571396
- Neoadjuvant Triple Therapy for Resectable HCCRecruitingNCT06569498
- Targeting Driver Oncogenes With a Peptide Vaccine Plus Durvalumab and Tremelimumab for Patients With Biliary Tract Cancers (BTC)RecruitingNCT06564623Phase 1
- The Efficacy of the IUrisure for Detection of Recurrent Urothelial CarcinomaRecruitingNCT06564363
- Sintilimab With Chemotherapy Plus PEG-rhG-GSF for Neoadjuvant Treatment of Esophageal Squamous Cell CarcinomaRecruitingNCT06563869Phase 3
- TPC VS. GP Induced Chemotherapy Combined With Nimotuzumab and Toripalimab in the Treatment of Locally Advanced Nasopharyngeal CarcinomaNot yet recruitingNCT06561763Phase 3
- Triple Therapy Sequential Radiotherapy in Unresectable HCC (TALENP003)RecruitingNCT06561399
- Individualized Tumor-Informed CtDNA Analysis for Monitoring Postoperative Recurrence in ESCC (NEOCRTEC2401)RecruitingNCT06561178
- Image Driven Hepatocellular Carcinoma Invasiveness Evaluation ResearchRecruitingNCT06559761
- Study of ZG005 Combined With Bevacizumab Versus Sintilimab Combined With Bevacizumab in Advanced Hepatocellular CarcinomaRecruitingNCT06558227Phase 2
- Pemigatinib and Immune Checkpoint Inhibitor Treated FGFR1/2/3 Alteration Advanced Solid TumorNot yet recruitingNCT06551896Phase 2
- Ablation of Oligometastasis Combined With Lenvatinib and PD-1 Inhibitor for Advanced Hepatocellular CarcinomaRecruitingNCT06550921Not applicable
- Retrospective Analysis of Patients With Metastatic Renal Cell Carcinoma Treated With CABOzantinibRecruitingNCT06548867
- A Study of Camrelizumab Plus Apatinib as Adjuvant Therapy in Patients With Hepatocellular Carcinoma at High Risk of Recurrence After Radical Resection or AblationNot yet recruitingNCT06546280Phase 2
- SCG142 TCR-T Cells for Human Papillomavirus-Associated CarcinomasRecruitingNCT06544720Phase 1
- Transfemoral Versus Transradial Approach in Transarterial Chemoembolization of Hepatocellular CarcinomaNot yet recruitingNCT06543030
- Study on the Classification of Comprehensive Treatment Effect of Hepatocellular CarcinomaRecruitingNCT06542796Not applicable
- Application of Integrated Proteomic and Serum Metabolomic Analysis in Assessing the Efficacy and Prognosis of TACE Combined With Targeted Immunotherapy in Unresectable Hepatocellular CarcinomaEnrolling by invitationNCT06540508
- Pilot Study of MPB-2043 Enhanced MRI for Nodal Staging in Head and Neck Squamous Cell CarcinomasRecruitingNCT06540443Phase 1
- SBRT Combined With Adbelimumab and Apatinib for Perioperative and Conversion Therapy of Hepatocellular CarcinomaNot yet recruitingNCT06538935Phase 2
- AK112 Plus AP Regimen for Operable Locally Advanced Head and Neck Squamous Cell CarcinomaNot yet recruitingNCT06537011Phase 2
- B-catenin in Cutaneous Squamous Cell Carcinoma and Its MimickersRecruitingNCT06536946